Page last updated: 2024-12-10
tnrnflrfamide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
TNRNFLRFamide: SCP (small cardioactive peptide)-like peptide found in lobster neurons; exhibits FMRFamide-like immunoreactivity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3081636 |
MeSH ID | M0191203 |
Synonyms (13)
Synonym |
---|
f1 peptide, lobster |
peptide f(1), lobster |
threonyl-asparaginyl-arginyl-asparaginyl-phenylalanyl-leucyl-arginyl-phenylalaninamide |
113611-68-0 |
l-phenylalaninamide, l-threonyl-l-asparaginyl-l-arginyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-arginyl- |
lobster peptide f1 |
thr-asn-arg-asn-phe-leu-arg-phe-nh2 |
(2s)-2-[[(2s)-2-[[(2s)-4-amino-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopenta |
tnrnflrfamide |
DTXSID50150488 |
(s)-n1-((s)-1-(((s)-1-(((s)-1-(((s)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((s)-2-((s)-4-amino-2-((2s,3r)-2-amino-3-hydroxybutanamido)-4-oxobutanamido)-5-g |
thr-asn-arg-asn-phe-leu-arg-phe-amide |
(2s)-2-[(2s,3r)-2-amino-3-hydroxybutanamido]-n-[(1s)-4-carbamimidamido-1-{[(1s)-1-{[(1s)-1-{[(1s)-1-{[(1s)-4-carbamimidamido-1-{[(1s)-1-carbamoyl-2-phenylethyl]carbamoyl}butyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-carbamoylethyl]c |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.63
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.63) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |